Britannia Life Sciences Inc. Share Price

Equities

BLAB

CA11042D1087

Food Processing

Market Closed - Canadian Securities Exchange 16:12:08 25/04/2024 BST 5-day change 1st Jan Change
0.06 CAD 0.00% Intraday chart for Britannia Life Sciences Inc. -14.29% -20.00%

Financials

Sales 2022 7.3 9.97 583.31 Sales 2023 6.4 8.74 511.71 Capitalization 15.41M 21.05M 1.23B
Net income 2022 -15M -20.48M -1.2B Net income 2023 5M 6.83M 400M EV / Sales 2022 4,701,582 x
Net Debt 2022 3.56M 4.87M 285M Net Debt 2023 5.81M 7.93M 464M EV / Sales 2023 3,314,262 x
P/E ratio 2022
-1.35 x
P/E ratio 2023
3.03 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 63.22%
More Fundamentals * Assessed data
Dynamic Chart
Britannia Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Britannia Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Britannia Life Sciences Inc. acquired additional 2% stake in Advanced Development & Safety Laboratories Limited for $0.943 million. CI
Britannia Life Sciences Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Britannia Life Sciences Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Britannia Life Sciences Inc. acquired 51% stake in COSMETICS LAB LTD for £0.1 million. CI
Britannia Life Sciences Inc. Appoints Shaun Compton as Managing Director of Britannia Mining Solutions CI
Britannia Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Britannia Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Britannia Life Sciences Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Britannia Life Sciences Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Britannia Life Sciences Inc. announced that it has received £5 million in funding from BOOST & Co. Limited CI
Britannia Life Sciences Inc. Announces Closing of Loan Facility CI
Britannia Life Sciences Inc. entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited. CI
Britannia Life Sciences Inc. Establishes New Subsidiary: Britannia Mining Solutions Inc CI
More news
1 week-14.29%
Current month-14.29%
1 month-14.29%
3 months-29.41%
Current year-20.00%
More quotes
1 week
0.06
Extreme 0.06
0.07
1 month
0.06
Extreme 0.06
0.07
Current year
0.06
Extreme 0.06
0.11
1 year
0.03
Extreme 0.03
0.13
3 years
0.03
Extreme 0.03
0.32
5 years
0.03
Extreme 0.03
0.32
10 years
0.03
Extreme 0.03
0.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 31/12/18
Director of Finance/CFO - 14/11/21
President - 14/11/21
Members of the board TitleAgeSince
Chairman - 14/11/21
Chief Executive Officer 43 31/12/18
Director/Board Member - 01/10/18
More insiders
Date Price Change Volume
25/04/24 0.06 0.00% 1,000

Delayed Quote Canadian Securities Exchange, April 25, 2024 at 04:12 pm

More quotes
Britannia Life Sciences Inc. is a Canada-based vertically diversified product development, quality assurance and safety and regulatory compliance company. The Company’s platform offers an integrated suite of services to assist companies along their product development journey. The Company provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. It is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations. Its services include product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations are offered to companies. It serves consumer-packaged goods (CPG), cosmetics, household goods, nutraceutical industries, notable multinationals, retailers, brands, blue-chip and small and medium enterprise clients.
More about the company